Share Facebook Twitter LinkedIn Pinterest Email KORU Medical Systems projects 20%–22% revenue growth for 2025 while advancing oncology and international expansion
Most and least shorted consumer discretionary stocks with up to $2B market cap as of end-March (XLY:NYSEARCA)April 3, 2026